|
|||
Clinical ProgramsAntipodean is working closely with the US and Australasian regulatory authorities, patient support groups and key physicians to design and conduct clinical study programs to establish the clinical efficacy of its lead product candidate, MitoQ®, in diseases of mitochondrial dysfunction. |
||||
|
||||